Pediatric Hematology and Oncology, St. Anna Children's Hospital, Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Vienna, Austria.
Children's Cancer Research Institute (CCRI), Vienna, Austria.
Pediatr Blood Cancer. 2019 Jul;66(7):e27691. doi: 10.1002/pbc.27691. Epub 2019 Mar 1.
Rothia mucilaginosa is part of the oral and upper respiratory tract flora. Usually, this gram-positive coccus is not pathogenic; however, in the setting of immunosuppressed hosts, it can cause life-threatening infections as an opportunistic pathogen. Among a cohort of 1511 hematologic-oncologic patients at a pediatric tertiary care cancer center, we identified five cancer patients (0.35%) within a period of 10 years having a proven Rothia mucilaginosa bacteremia (1 culture positive: n = 3/5; > 1 culture positive: n = 2/5). With prompt and adequate antibiotic treatment, infection resolved rapidly before recovery of neutrophils and without any sequelae, suggesting that Rothia mucilaginosa bacteremia without organ involvement is not exceptionally problematic in pediatric cancer patients.
粘质罗斯菌是口腔和上呼吸道菌群的一部分。通常,这种革兰阳性球菌不是病原体;然而,在免疫抑制宿主中,它可以作为机会性病原体引起危及生命的感染。在一家儿科三级癌症中心的 1511 例血液肿瘤患者队列中,我们在 10 年内发现了 5 例癌症患者(0.35%)患有粘质罗斯菌菌血症(1 次培养阳性:n=3/5;>1 次培养阳性:n=2/5)。在快速和充分的抗生素治疗下,在中性粒细胞恢复之前,感染迅速得到解决,没有任何后遗症,这表明儿童癌症患者无器官受累的粘质罗斯菌菌血症并不是特别成问题。